RecruitingCancerDepression
Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to determine the extent to which an online pathway to depression treatment (iPath\*D) is acceptable and usable to patients receiving cancer treatment who report symptoms of depression.
Sponsor: Dartmouth-Hitchcock Medical Center
You may qualify if…
- ✓ 1. Adults (≥18 years)
- ✓ 2. New patients who are beginning treatment at Dartmouth Cancer Center North and returning for their chemo teach or radiation simulation visit
- ✓ 3. Can communicate in English
- ✓ 4. PHQ-9 ≥10 and ≤27
You may not qualify if…
- ✕ 1. Mild Depression (PHQ-9 ≥10)
- ✕ 2. Individuals who screen positive for suicidal ideation with method, intent, plan or a recent prior suicide/self-harm attempt, as determined by a positive endorsement of items 3, 4, 5 or 6 on the Columbia-Suicide Severity Rating Scale (C-SSR).
- ✕ 3. Individuals with bipolar disorder or psychosis (documented in the EMR)
- ✕ 4. Individuals currently receiving treatment for a mental health condition (documented in the EMR or self-reported during eligibility screening)
- ✕ 5. Significant cognitive impairment (Callahan's Six Item Screener of cognitive function ≤ 4; Self-reported during eligibility screening)
Where it's recruiting
Vermont
Saint Johnsbury
Source: ClinicalTrials.gov · NCT05302375 · last updated 2025-04-03